Login
$DH
$1.28 +$0.02 (1.59%) After hours

$DH SEC Filings

Filed On Filing
09 Nov 2026 SCHEDULE 13G/A
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Third Quarter Revenue Within Guidance Range; Profit Surpasses Expectations

03 Nov 2026 Form 4: Krantz Jason Ronald, Director

Gave up 12,166 shares to cover exercise price or tax ($13.6K)

03 Nov 2026 Form 4: Heller Casey, Chief Financial Officer

Gave up 1,881 shares to cover exercise price or tax ($2.11K)

27 Oct 2026 Form 4: Ritchey Clay Brian, Director

Received 2,626,263 shares as a grant or award

05 Oct 2026 Form 4: Heller Casey, Chief Financial Officer

Gave up 12,542 shares to cover exercise price or tax ($11.7K)

05 Oct 2026 Form 4: Paris Jonathan, Chief Legal Officer

Gave up 7,729 shares to cover exercise price or tax ($7.24K)

01 Oct 2026 SCHEDULE 13D/A
16 Sep 2026 Form 3: Ritchey Clay Brian, Director

Holds 5,000 shares of Class A Common Stock

09 Sep 2026 8-K: Regulation FD Disclosure

As previously disclosed, Definitive Healthcare Corp. (the “Company”) is party to a tax receivable agreement, dated as of September 14, 2021 (the “TRA”), with AIDH TopCo, LLC, certain affiliates of Advent International, L.P. (collectively...

03 Sep 2026 Form 4: Heller Casey, Chief Financial Officer

Gave up 41,093 shares to cover exercise price or tax ($37.1K)

02 Sep 2026 8-K: Other Events

Framingham, Mass., Sept. 2, 2026 (GLOBE NEWSWIRE) – The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and a...

02 Sep 2026 SCHEDULE 13D
02 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

We are pleased to offer you the position of Chief Executive Officer at Definitive Healthcare, LLC, a Massachusetts limited liability company (the “Company”) and its parent company, Definitive Healthcare Corp., a Delaware corporation (“Pa...

02 Sep 2026 SCHEDULE 13D
10 Aug 2026 10-Q
10 Aug 2026 8-K: Results of Operations and Financial Condition

Second Quarter Revenue Within Guidance Range; Profit Surpasses Expectations

04 Aug 2026 Form 4: Krantz Jason Ronald, Director

Gave up 12,166 shares to cover exercise price or tax ($8.3K)

04 Aug 2026 Form 4: Heller Casey, Chief Financial Officer

Gave up 1,881 shares to cover exercise price or tax ($1.28K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support